It is already known that a reduction in gut microbial richness is the hallmark change of human immunodeficiency virus (HIV) infection, but how this dysbiosis is established in the HIV-exposed uninfected infant is poorly understood. A recent cross-sectional study, led by Dr. Grace M. Aldrovandi from the Children’s Hospital Los Angeles in Los Angeles (USA), suggests that perturbations in the infant gut microbiome may explain the greater risk of morbidity and mortality in uninfected babies born to HIV-positive mothers.

It has been previously reported that the gut microbiota could be involved in the pathogenesis of metabolic diseases such as diabetes. A recent study, led by Dr. Wolfgang zu Castell from the Scientific Computing Research Unit at Helmholtz Zentrum München in Munich (Germany) has found that butyrate may have a protective effect in the pathogenesis of type 1 diabetes.

A recent study, led by Dr. Menghui Zhang from the State Key Laboratory of Microbial Metabolism at Shanghai Jiao Tong University (China), has shown that gut resistome of obese children is reduced after a dietary intervention.

Inappropriate use of antibiotics promotes the emergence of multidrug-resistant pathogens, such as Vancomycin-resistant Enterococci (VRE), Methicillin-resistant Staphylococcus aureus (MRSA), and Multidrug-resistant (MDR) Enterobacteriaceae, which justifies the search for alternative clinical approaches.

A recent commentary in Nature Reviews Gastroenterology & Hepatology, written by Dr. Susan E. Erdman from the Division of Comparative Medicine at the Massachusetts Institute of Technology in Cambridge (USA), has covered the role of microbial strategies in cancer prevention and remission.

Go to Top